UCM-05194
Product Specifications
UNSPSC Description
UCM-05194 is a selective LPA1 receptor agonist with activity to improve neuropathic pain. UCM-05194 is a LPA1 agonist that exhibits potent and selective properties in its pharmacologically similar properties. UCM-05194 triggers LPA1-mediated cellular effects and leads to internalization of the receptor, resulting in functional inactivation in primary sensory neurons. UCM-05194 effectively reduces pain perception in in vivo models. UCM-05194 can be used to conduct research on progressive systemic diseases[1].
Target Antigen
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ucm-05194.html
Smiles
O=P(O)(O)OC[C@@H](CBr)OC(CCCCCCCCCC1=CC=CC=C1)=O
Molecular Weight
465.32
References & Citations
[1]A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-167862/UCM-05194-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-167862/
Clinical Information
No Development Reported
CAS Number
2411412-36-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1306362 Inquire
Recombinant Human Serine/threonine-protein kinase TNNI3K (TNNI3K) , partial
Ask
View Details 
